insights_auto
Why is CUV up 2.22%?
Dive Deeperchevron_right
CUV:ASX
Clinuvel Pharmaceuticals Ltd
A$7.58
arrow_upward
+2.22%(+0.16) 1D
Nov 16, 2:42:32 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CUV...
Open
A$7.43
High
A$7.65
Low
A$7.38
Mkt. cap
382.94M
Avg. vol.
157.65K
Volume
69.20K
Dividend
0.66%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.35
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
Open
A$7.43
High
A$7.65
Low
A$7.38
Mkt. cap
382.94M
Avg. vol.
157.65K
Volume
69.20K
Dividend
0.66%
Quarterly dividend
A$0.01
Ex-dividend date
Sep 3, 2026
P/E ratio
11.35
52-wk high
A$13.48
52-wk low
A$6.62
EPS
A$0.67
Shares outstanding
50.49M
No. of employees
16
News stories
From web sources and news partners
investingLive
·
1 hour ago
Morgan Stanley goes max overweight global stocks, sees 15% S&P 500 upside on AI capex
The Motley Fool
·
9 hours ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
TradingKey
·
1 day ago
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
BigGo Finance
·
14 hours ago
Goldman Sachs Sets 8,700 S&P 500 Target for 2027, Sees 14% Upside as AI Capex Peaks
About Clinuvel Pharmaceuticals Ltd
CEOPhilippe J. Wolgen
Employees16
Founded1987
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteclinuvel.com